IL-1 augments TNF - Mediated inflammatory responses from lung epithelial cells

Journal of Interferon and Cytokine Research

Volumn 29, Issue 5, 2009, Pages 273-284

  Saperstein, Sara ^a   Chen, Linlin ^a   Oakes, David ^a   Pryhuber, Gloria ^a   Finkelstein, Jacob ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; INTERLEUKIN 1BETA; KC PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; NEUTRALIZING ANTIBODY; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; METALLOPROTEINASE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EPITHELIUM CELL; INFLAMMATION; LUNG ALVEOLUS CELL; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; ANIMAL; CELL LINE; CELL MEMBRANE; DRUG EFFECT; GENETICS; LUNG; METABOLISM; PATHOLOGY; SECRETION;

ANIMALS; CELL LINE; CELL MEMBRANE; CHEMOKINE CXCL1; CHEMOKINE CXCL2; EPITHELIAL CELLS; INFLAMMATION; INTERLEUKIN-1BETA; LUNG; METALLOPROTEASES; MICE; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66749117828     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2008.0076     Document Type: Article

References (52)

1. Aggarwal BB. 2003. Signalling pathways of the TNF superfamily: a double-edged sword. Nature Rev Immunol 3(9):745-756.
2. Bachurski CJ, Pryhuber GS, Glasser SW, Kelly SE, Whittset JA. 1995. Tumor necrosis factor-alpha inhibits surfactant protein C gene transcription. J Biol Chem 270(33):19402-19407.
3. Barbara JA, Smith WB, Gamble JR, Van Ostade X, Vandenabeele P, Tavernier J, Fiers W, Vadas MA, Lopez AF. 1994. Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-alpha mutants. EMBO J 13:843-850.
4. Barrett EG, Johnston C, Oberdorster G, Finkelstein JN. 1998. Silica-induced chemokine expression in alveolar type II cells is mediated by TNF-α. Am J Physiol Lung Cell Mol Physiol 275(6 Pt 1):L1110-L1119.
5. Barrett EG, Johnston C, Oberdorster G, Finkelstein JN. 1999. Silica-induced chemokine expression in alveolar type II cells is mediated by TNF-α-induced oxidant stress. Am J Physiol Lung Cell Mol Physiol 276(6 Pt 1):L979-L988.
6. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March C, Cerretti DP. 1997. A metalloproteinase disintegrin that releases tumour necrosis factor-alpha from cells. Nature 385(6618):729-733.
7. Calkins CM, Heimbach JK, Bensard DD, Song Y, Raeburn CD, Meng X, Mclntyre RC Jr. 2001. TNF receptor 1 mediates chemokine production and neutrophil accumulation in the lung following systemic lipopolysaccharide. J Sci Res 101(2):232-237.
8. Cardell LO, Uddman R, Zhang Y, Adner M. 2008. Interleukin-lbeta up-regulates tumor necrosis factor receptors in the mouse airways. Pulm Pharmacol Ther 21(4):675-681.
9. Crowe PD, Walter BN, Mohler KM, Ottens-Evans C, Black RA, Ware CF. 1995. A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med 181(3):1205-1210.
10. Cui X, Hawari F, Alsaaty S, Lawrence M, Combs CA, Geng W, Rouhani FN, Miskinis D, Levine SJ. 2002. Identification of ARTS-1 as a novel TNFRl-binding protein that promotes TNFR1 ectodomain shedding. J Clin Invest 110(4)515-526.
11. Dinarello CA. 1994. The biological properties of interleukin-1. Eur Cytokine Netw 5(6)517-531.
12. Doszczak M, Pierzchalski A, Grzenkowicz J, Stasilojc G, Bigda JJ. 2008. Cytocidal effect of interleukin 1 (IL-1) on HeLa cells is mediated by both soluble and transmembrane tumor necrosis factor (TNF). Cytokine 42(2):243-255.
13. Driscoll KE. 1994. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp Lung Res 20(6):473-490.
14. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D. 1989. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem 264(20):11974-11980.
15. Gozal E, Ortiz LA, Zou X, Burow ME, Lasky JA, Friedman M. 2002. Silica-induced apoptosis in murine macrophages. Am J Respir Cell Mol Biol 27(1):91-98.
16. Higuchi M, Aggarwal BB. 1994. TNF induces internalization of the p60 receptor and shedding of the p80 receptor. J Immunol 152(7):3550-3558.
17. Holtmann H, Wallach D. 1987. Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate. J Immunol 139(4):1161-1167.
18. Hultner L, Kolsch S, Stassen M, Kaspers U, Kremer JP, Mailhammer R, Moeller J, Broszeit H, Schmitt E. 2000. In activated mast cells, IL-1 up-regulates the production of several Th2-related cytok-ines including IL-9. J Immunol 164(11)5556-5563.
19. Jones BW, Song GJ, Greuber EK, Hinkle PM. 2007. Phosphorylation of the endogenous thyrotropin releasing hormone receptor in pituitary GH3 cells and pituitary tissue revealed by phosphosite-specific antibodies. J Biol Chem 282(17):12893-12906.
20. Kida Y, Kobayashi M, Suzuki T, Takeshita A, Okamatsu Y, Hanazawa S, Yasui T, Haseqawa K. 2005. Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of M APK/AP-1 and NF-kappaB in human gingival fibroblasts. Cytokine 29(4):159-168.
21. Kull FC Jr, Cuatrecasas P. 1981. Possible requirement of internalization in the mechanism of in vitro cytotoxicity in tumor necrosis serum. Cancer Res 41(12 Pt 1):4885-4890.
22. Le J, Vilcek J. 1987. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 56(3):234-248.
23. Levine SJ, Logun C, Chopra DP, Rhim JS, Shelhamer JH. 1996. Protein kinase C, interleukin-1 beta, and corticosteroids regulate shedding of the type I, 55 kDa TNF receptor from human airway epithelial cells. Am J Respir Cell Mol Biol 14(3):254-261.
24. Levine SJ, Adamik B, Hwari F, Islam A, Yu Z, Liao D, Cui X, Rouhani F. 2005. Proteasome inhibition induces TNFR1 shedding from human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol 289(2):L233-L243.
25. Li X, Fan PL 2005. Loss of ectodomain shedding due to mutations in the metalloprotease and cysteine rich/disintegrin domains of the tumor necrosis factor-alpha converting enzyme (TACE). J Biol Chem 279(26):27365-27375.
26. MacEwan DJ. 2002. TNF receptor subtype signaling: differences and cellular consequences. Cell Signal 14(6):477-492.
27. Mullberg J, Durie FH, Otten-Evans C, Alderson MR, Rose-Johns S, Cosman D, Black RA, Mohler KM. 1995. A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol 155(11)5198-5205.
28. Ohe H, Takashiba S, Naruishi K, Chou H, Yamada H, Nishimura F, Arai H, Murayama Y 2000. Tumor necrosis factor-α (TNF-α)-induced and interleukin-lβ (IL-lβ) induced shedding of TNF receptors from gingival fibroblasts. J Interferon Cytokine Res 20(12):1077-1082.
29. Paland N, Bohme L, Gurumurthy RK, Maurer A, Szczepek AJ, Rudel T. 2008. Reduced display of tumor necrosis factor receptor I at the host cell surface supports infection with Chlamydia trackomatis. J Biol Chem 283(10):6438-6448.
30. Pan LH, Ohtani H, Yamauchi K, Nagura H. 1996. Co-expression of TNF-α and IL-lβ in human acute pulmonary fibrotic diseases: an immunohistochemical analysis. Pathol Int 46(2):91-99.
31. Parsons PE, Matthay MA, Ware LB, Eisner MD; National Heart, Lung, Blood Institute Acute Respiratory Distress Syndrome Clinical Trials Network. 2005. Elevated plasma levels of soluble TNF receptors are associated with morbidity and mortality in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 288(3):L426-L431.
32. Peschon JJ, Slack JL, Reddy P, Stocking KL, Sunnarborg SW, Lee DC, Russell WE, Castner BJ, Johnson RS, Fitzner JN, Boyce RW, Nelson N, Kozlosky CJ, Wolfson MF, Rauch CT, Cerretti DP, Paxton RJ, March CJ, Black RA. 1998. An essential role for ectodomain shedding in mammalian development. Science 282(5392):1281-1284.
33. Piguet PF, Collart MA, Grau GE, Sappino AP, Vassalli P. 1990. Requirement of tumor necrosis factor for development of silica-induced pulmonary fibrosis. Nature (6263):245-247.
34. Pinckard JK, Sheehan KC, Arthur CD, Schreiber RD. 1997. Constitutive shedding of both p55 and p75 murine TNF receptors in vivo. J Immunol 158:3869-3873.
35. Pinckard JK, Sheehan KC, Schreiber RD. 1997. Ligand-induced formation of p55 and p75 tumor necrosis factor receptor heterocom-plexes on intact cells. J Biol Chem 272(16):10784-10789.
36. Porteu F, Brockhaus M, Wallach D, Engelmann H, Nathan CF. 1991. Human neutrophil elastase release a ligand-binding fragment from the 75-kDa tumor necrosis factor (TNF) receptor. J Biol Chem 266(28):18846-18853.
37. Pryhuber GS, Huyck HL, Baggs R, Oberdorster G, Finkelstein JN. 2003. Induction of chemokines by low-dose intratracheal silica is reduced in TNFRI (p55) null mice. Toxicol Sci 72(1): 14608-14614.
38. Reddy P, Slack JL, Davis R, Cerretti DP, Kozlosky CJ, Blanton RA, Shows D, Peschon JJ, Black RA. 2000. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275(19):14608-14614.
39. Rothe J, Bluethmann H, Gentz R, Lesslauer W, Steinmetz M. 1993. Genomic organization and promoter function of the mu-rine tumor necrosis factor receptor beta gene. Mol Immunol 30(2):165-175.
40. Schlondorff J, Becherer JD, Blobel CR 2000. Intracellular maturation and localization of the tumour necrosis factor alpha convertase (TACE). Biochem J 347(pt 1):131-138.
41. Schneider-Brachert W, Tchikov V, Neumeyer J, Jakob M, Winoto-Morbach S, Held Feindt J, Heinrich M, Merkel O, Ehrenschwender M, Adam D, Mentlein R, Kabelitz D, Schutze S. 2004. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21(3):415-428.
42. Sebag JA, Hinkle PM. 2007. Melanocortin-2 receptor accessory protein MRAP forms antiparallel homodimers. Proc Natl Acad Sci USA 104(51):20244-20249.
43. Shimomoto H, Hasegawa Y, Nozaki Y, Takagi N, Shibagaki T, Nakao A, Shimokata K. 1995. Expression of tumor necrosis factor receptors in human lung cancer cells and normal lung tissues. Am J Respir Cell Mol Biol 13(3):271-278.
44. Skerrett SJ, Martin TR, Chi EY, Peschon JJ, Mohler KM, Wilson CB. 1999. Role of the type I TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa. Am J Physiol 276(5 Pt 1):L715-L727.
45. Smith MR, Munger WE, Kung HF, Takacs L, Durum SK. 1990. Direct evidence for an intracellular role for tumor necrosis factor-alpha 1. Microinjection of tumor necrosis factor kills target cells. J Immunol 144(5):162-169.
46. Smith S, Skerret SH, Chi EY, Jonas M, Mohler K, Wilson CB. 1998. The locus of tumor necrosis factor-α action in lung inflammation. Am J Respir Cell Mol Biol 19(6):881-891.
47. Tartaglia LA, Pennica D, Goeddel DV. 1993. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 268(25):18542-18548.
48. Weiss T, Grell M, Siemienski K, Muhlenbeck F, Durkop H, Pfizenmaier K, Scheurich P, Wajant H. 1998. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J Immunol 161(6):3136-3142.
49. Winzen R, Wallach D, Kemper O, Resch K, Holtmann H. 1993. Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J Immunol 150(10):4346-4353.
50. Wright TW, Pryhuber GS, Chess PR, Wang Z, Notter RH, Gigliotti F. 2004. TNF receptor signaling contributes to chemokine secretion, inflammation, and respiratory deficits during Pneumocystis pneumonia. J Immunol 172(4):2511-2521.
51. Zhang H, Yan D, Shi X, Liang H, Pang Y, Qin N, Chen H, Wang J, Yin B, Jiang X, Feng W, Zhang W, Zhou M, Li Z. 2008. Transmembrane TNF-alpha mediates "forward" and "reverse" signaling, inducing cell death or survival via the NF-kappaB pathway in Raji Burkitt lymphoma cells. 84(3):789-797.
52. Ziegenhagen MW, Fitschen J, Martinet N, Schlaak M, Miiller-Quernheim J. 2000. Serum levels of soluble tumor necrosis factor receptor II (75kDa) indicates inflammatory activity of sarcoid-osis. J Intern Med 248(1):33-41.